Literature DB >> 21729920

The private sector role in HIV/AIDS in the context of an expanded global response: expenditure trends in five sub-Saharan African countries.

Sara Sulzbach1, Susna De, Wenjuan Wang.   

Abstract

Global financing for the HIV response has reached unprecedented levels in recent years. Over US$10 billion were mobilized in 2007, an effort credited with saving the lives of millions of people living with HIV (PLHIV). A relatively unexamined aspect of the global HIV response is the role of the private sector in financing HIV/AIDS services. As the nature of the response evolves from emergency relief to long-term sustainability, understanding current and potential contributions from the private sector is critical. This paper examines trends in private sector financing, management and resource consumption related to HIV/AIDS in five sub-Saharan African countries, with a particular emphasis on the effects of recently scaled-up donor funding on private sector contributions. We analysed National Health Accounts HIV/AIDS subaccount data for Kenya, Malawi, Rwanda, Tanzania and Zambia between 2002 and 2006. HIV subaccounts provide comparable data on the flow of HIV/AIDS funding from source to use. Findings indicate that private sector contributions decreased in all countries except Tanzania. With regards to managing HIV/AIDS funds, non-governmental organizations are increasingly controlling the largest share of resources relative to other stakeholders, whereas private for-profit entities are managing fewer HIV/AIDS resources since the donor influx. The majority of HIV/AIDS funds were spent in the public sector, although a considerable amount was spent at private facilities, largely fuelled by out-of-pocket (OOP) payments. On the whole, OOP spending by PLHIV decreased over the 4-year period, with the exception of Malawi, demonstrating that PLHIV have increased access to free or subsidized HIV/AIDS services. Our findings suggest that the influx of donor funding has led to decreased private contributions for HIV/AIDS. The reduction in private sector investment and engagement raises concerns about the sustainability of HIV/AIDS programmes over the long term, particularly in light of current global economic crisis and emerging competing priorities.

Entities:  

Mesh:

Year:  2011        PMID: 21729920     DOI: 10.1093/heapol/czr031

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  6 in total

1.  Patient satisfaction with HIV/AIDS care at private clinics in Dar es Salaam, Tanzania.

Authors:  James S Miller; Aisa Mhalu; Guerino Chalamilla; Hellen Siril; Silvia Kaaya; Justina Tito; Eric Aris; Lisa R Hirschhorn
Journal:  AIDS Care       Date:  2014-02-06

Review 2.  Does ownership matter? An overview of systematic reviews of the performance of private for-profit, private not-for-profit and public healthcare providers.

Authors:  Cristian A Herrera; Gabriel Rada; Lucy Kuhn-Barrientos; Ximena Barrios
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

3.  Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria.

Authors:  Muyi Aina; Zeena Yesufu; Abdulateef Salisu; Echezona Ezeanolue; Charles Mensah; Patrick Dakum
Journal:  AIDS Res Ther       Date:  2022-02-22       Impact factor: 2.250

Review 4.  Public stewardship of private for-profit healthcare providers in low- and middle-income countries.

Authors:  Charles S Wiysonge; Leila H Abdullahi; Valantine N Ndze; Gregory D Hussey
Journal:  Cochrane Database Syst Rev       Date:  2016-08-11

Review 5.  Exploring Relative Preferences for HIV Service Features Using Discrete Choice Experiments: a Synthetic Review.

Authors:  I Eshun-Wilson; H-Y Kim; S Schwartz; M Conte; D V Glidden; E H Geng
Journal:  Curr HIV/AIDS Rep       Date:  2020-10       Impact factor: 5.071

6.  Factors influencing adherence to antiretroviral treatment among adults accessing care from private health facilities in Malawi.

Authors:  Lusungu Chirambo; Martha Valeta; Tifiness Mary Banda Kamanga; Alinane Linda Nyondo-Mipando
Journal:  BMC Public Health       Date:  2019-10-28       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.